<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANG</journal-id>
<journal-id journal-id-type="hwp">spang</journal-id>
<journal-id journal-id-type="nlm-ta">Angiology</journal-id>
<journal-title>Angiology</journal-title>
<issn pub-type="ppub">0003-3197</issn>
<issn pub-type="epub">1940-1574</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0003319711414865</article-id>
<article-id pub-id-type="publisher-id">10.1177_0003319711414865</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Coronary Heart Disease</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Arterial Ultrasound Screening as a Tool for Coronary Risk Assessment in Asymptomatic Men and Women</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Cournot</surname>
<given-names>Maxime</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0003319711414865">1</xref>
<xref ref-type="corresp" rid="corresp1-0003319711414865"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bura</surname>
<given-names>Alessandra</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff2-0003319711414865">2</xref>
<xref ref-type="aff" rid="aff3-0003319711414865">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cambou</surname>
<given-names>Jean-Pierre</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0003319711414865">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taraszkiewicz</surname>
<given-names>Dorota</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0003319711414865">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maloizel</surname>
<given-names>Julie</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0003319711414865">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Galinier</surname>
<given-names>Michel</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff4-0003319711414865">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Broutin</surname>
<given-names>Hélène Hanaire</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff5-0003319711414865">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chamontin</surname>
<given-names>Bernard</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff6-0003319711414865">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carrié</surname>
<given-names>Didier</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff4-0003319711414865">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferrieres</surname>
<given-names>Jean</given-names>
</name>
<degrees>MD, MSc, FESC</degrees>
<xref ref-type="aff" rid="aff4-0003319711414865">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-0003319711414865"><label>1</label>Department of cardiology, Centre Hospitalier du Val d’Ariège, Foix, France</aff>
<aff id="aff2-0003319711414865"><label>2</label>Department of Vascular Medicine, CHU Rangueil, Toulouse, France</aff>
<aff id="aff3-0003319711414865"><label>3</label>INSERM U858, Toulouse, France</aff>
<aff id="aff4-0003319711414865"><label>4</label>Preventive Cardiology Unit, CHU Rangueil, Toulouse, France</aff>
<aff id="aff5-0003319711414865"><label>5</label>Department of Diabetology, CHU Rangueil, Toulouse, France</aff>
<aff id="aff6-0003319711414865"><label>6</label>Department of Internal Medicine and Hypertension, CHU Rangueil, Toulouse, France</aff>
<author-notes>
<corresp id="corresp1-0003319711414865">Maxime Cournot, Centre Hospitalier du Val d’Ariège, BP01, 09017 Foix cedex, France Email: <email>maximecournot@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>63</volume>
<issue>4</issue>
<fpage>282</fpage>
<lpage>288</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>One of the imaging tests most commonly used to assess cardiovascular diseases (CVDs) in daily practice is Doppler ultrasonography of the carotid and femoral arteries. We included 2709 participants with no history or symptoms of CVD; they had a risk factor assessment and a carotid and femoral ultrasonography at baseline. Incident cases of definite coronary events were recorded during a median follow-up of 6 years. Approximately, 63% of the sample presented abnormalities (carotid stenosis &gt;50%, carotid plaque, femoral plaque, increased intima–media thickness [IMT]). A moderately increased IMT (&gt;0.63 mm) or the presence of carotid or femoral artery plaque was related to prognosis. The associations persisted after adjustment for pretest risk, treatment with statins, and other Doppler ultrasonography abnormalities. The hazard ratio increased significantly with the number of abnormalities (varying from 2.35 [1.16-4.74] to 14.83 [6.47-33.9]).</p>
</abstract>
<kwd-group>
<kwd>intima–media thickness</kwd>
<kwd>femoral plaque</kwd>
<kwd>carotid plaque</kwd>
<kwd>arterial ultrasonography</kwd>
<kwd>coronary heart disease</kwd>
<kwd>screening</kwd>
<kwd>cohort study</kwd>
<kwd>primary prevention</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0003319711414865">
<title>Introduction</title>
<p>According to international recommendations, the estimate of absolute risk of a first coronary event in asymptomatic adults is based on the assessment of conventional risk factors introduced into a risk equation.<sup>
<xref ref-type="bibr" rid="bibr1-0003319711414865">1</xref>,<xref ref-type="bibr" rid="bibr2-0003319711414865">2</xref>
</sup> But this estimate of risk is imperfect because of geographical variations and characteristics not taken into account in the formulae, such as, psychosocial, nutritional, or climate factors. With a view to improving the quality and reliability of risk prediction, a search for subclinical atherosclerosis or arterial function abnormality, using additional, noninvasive explorations, should enable the detection of groups of patients at high cardiovascular risk undetected by risk factors alone. In this context, the choice of examinations which are of practical use should tend toward tests that can offer an additional prognostic contribution, are not costly, and are noninvasive.</p>
<p>One of the additional tests most commonly used in daily practice is arterial Doppler ultrasonography. However, the prognostic significance of any abnormalities detected by Doppler ultrasonography of the carotid and/or femoral arteries, and the practical steps to be taken when these abnormalities are detected, remain uncertain because little evidence on the subject exists. It has been shown that the introduction of algorithms for the prediction of certain risk markers evidencing arterial damage might improve the prediction of risk.<sup>
<xref ref-type="bibr" rid="bibr3-0003319711414865">3</xref>
</sup> For example, the carotid intima–media thickness (IMT), the presence of plaques in the carotid or femoral arteries, and the ankle–brachial index (ABI) have all been correlated with classic risk factors<sup>
<xref ref-type="bibr" rid="bibr4-0003319711414865">4</xref>,<xref ref-type="bibr" rid="bibr5-0003319711414865">5</xref>
</sup> and to coronary risk.<sup>
<xref ref-type="bibr" rid="bibr6-0003319711414865">6</xref><xref ref-type="bibr" rid="bibr7-0003319711414865"/>–<xref ref-type="bibr" rid="bibr8-0003319711414865">8</xref>
</sup> These markers have been studied in isolation. On the other hand, the interest of a full vascular checkup with a Doppler ultrasonography including all of these parameters has not, to our knowledge, been studied.</p>
<p>The aim of the present EVADEC-VASC study (EVAluation du DEpistage de la Coronaropathie—VASCulaire [Assessment of screening for coronary artery disease and vascular disease]) was to assess the ability of the various abnormalities detected with a Doppler ultrasonography to predict the occurrence of coronary events, above and beyond the conventional risk factors.</p>
</sec>
<sec id="section2-0003319711414865">
<title>Methods</title>
<sec id="section3-0003319711414865">
<title>Participants</title>
<p>We conducted a prospective cohort study which included 2709 apparently healthy asymptomatic participants. Participants were included between January 1996 and December 2004 in the preventive cardiology department of our teaching hospital (CHU Rangueil, Toulouse, France). Men and women between 18 and 75 years old, with no personal history of cardiovascular disease (CVD) or any cardiovascular symptoms were eligible for recruitment. In total, 53% were referred by physicians from our teaching hospital, mainly from outpatient departments of diabetology, internal medicine, cardiology, endocrinology, or vascular medicine. Patients were assessed in the previously cited departments for reasons other than cardiovascular symptoms. In total, 27% were referred by their regular primary care physician. General practitioners of the administrative district of our hospital were informed through post and meetings. According to the inclusion criteria, patients had to be free of any cardiovascular symptom. In all, 20% were self-referred for an evaluation of their coronary risk and had known about the study from announcements or by meetings scheduled for the general population. All participants had a standardized examination protocol, including history taking, physical examination, blood hematology and biochemistry tests, resting electrocardiography, cardiac cycloergometer exercise testing, and carotid and femoral duplex ultrasonography. Data on the diagnostic value of physical examination<sup>
<xref ref-type="bibr" rid="bibr9-0003319711414865">9</xref>
</sup> and on the additional value of various noninvasive tests<sup>
<xref ref-type="bibr" rid="bibr10-0003319711414865">10</xref>
</sup> have been published elsewhere. However, these analyses did not investigate the prognostic information provided by each arterial abnormality or finding.</p>
</sec>
<sec id="section4-0003319711414865">
<title>Risk Factors</title>
<p>On the day of enrollment, all participants provided information about their cardiovascular risk factors and lifestyle through a standardized questionnaire derived from the MONICA population survey.<sup>
<xref ref-type="bibr" rid="bibr11-0003319711414865">11</xref>
</sup> The data recorded included a medical history of CVD risk factors, medication, alcohol consumption, and socioprofessional data. The risk factors taken into account were age (≥45 years for men, ≥55 years for women), current cigarette use, hypertension (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg, or documented use of antihypertensive drugs), diabetes mellitus (fasting glucose level ≥126 mg/dL or documented use of antidiabetic drugs), hypercholesterolemia (low-density lipoprotein [LDL]-cholesterol ≥4.14 mmol/L or documented use of lipid-lowering drugs), low high-density lipoprotein [HDL] cholesterol level (&lt;1.03 mmol/L for men and &lt;1.29 for women), family history of premature coronary heart disease ([CHD] before 55 years in father or brother/65 years in mother or sister), and overweight (body mass index ≥25 kg/m<sup>2</sup>). Four levels of leisure time physical activity were defined: no regular physical activity, mild physical activity (ie, less than once a week), moderate physical activity (ie, 20 minutes at least, once or twice a week), and high physical activity (ie, 20 minutes at least, 3 times a week or more). Metabolic syndrome was defined according to the NCEP criteria.<sup>
<xref ref-type="bibr" rid="bibr12-0003319711414865">12</xref>
</sup> Baseline absolute cardiovascular risk was assessed using a 10-year Framingham risk function<sup>
<xref ref-type="bibr" rid="bibr13-0003319711414865">13</xref>
</sup> that requires age, sex, current smoking, diabetes, total cholesterol, and HDL cholesterol. We also assessed the overall risk of cardiac death using the SCORE European function.<sup>
<xref ref-type="bibr" rid="bibr2-0003319711414865">2</xref>
</sup>
</p>
</sec>
<sec id="section5-0003319711414865">
<title>Duplex Ultrasound</title>
<p>The physician who performed the ultrasonography was blinded for the medical history and physical examination results. Bilateral common and internal carotid artery, as well as femoral artery scanning was performed using an ATL UM9 (Advanced Technology Laboratory Ultramark 9 High Definition imaging, Phillips, France) system with a 7.4-MHz transducer. The IMT was defined as the distance between the media–adventitia interface and the lumen–intima interface, avoiding the sites of plaque. The IMT was measured on the right and left common carotid arteries, only on the far wall: 3 points at 2 locations on each artery (proximal and middle), with about 10 to 15 mm intervals, the most cranial point being 15 to 20 mm from the bifurcation.</p>
<p>Standard flow velocity criteria were used for grading the severity of carotid stenosis.<sup>
<xref ref-type="bibr" rid="bibr14-0003319711414865">14</xref>
</sup> Internal, common carotid, and femoral plaques were defined as a distinct area identified with either a focal area of hyperechogenicity and or a focal protrusion into the lumen of the vessel.</p>
<p>An abnormal arterial ultrasonography was defined by the presence of at least 1 of the following criteria: carotid stenosis (&gt;50%), carotid plaque, femoral plaque, abdominal aorta aneurysm &gt;30 mm, and IMT &gt; 0.63 mm. A cutoff of 0.63 mm was chosen for the IMT because it was the median value of our sample.</p>
</sec>
<sec id="section6-0003319711414865">
<title>Follow-up and end points</title>
<p>Morbidity and mortality data were obtained by mailed questionnaires or by telephone calls to patients and to their regular physicians. The survey was conducted in 2006. Each reported case and causes of deaths were coded by a medical committee after review of the medical records and the physicians' interviews, according to the PRIME study definitions.<sup>
<xref ref-type="bibr" rid="bibr15-0003319711414865">15</xref>
</sup>
</p>
<p>The primary end point of this study was the occurrence of definite coronary events, including cardiac deaths, sudden deaths, acute myocardial infarction, and stable or unstable angina. Revascularization (coronary artery bypass surgery or percutaneous coronary intervention) without clinical symptom was not considered a coronary event. The median follow-up was 6 years.</p>
</sec>
<sec id="section7-0003319711414865">
<title>Statistical analysis</title>
<p>Analysis of variance and chi-square tests were used for comparisons between groups. Kaplan-Meier cumulative event curves were constructed to describe the incidence of coronary events since enrollment.</p>
<p>Event-free survival functions were computed using the Kaplan-Meier method. Univariate and multivariate associations between markers obtained at arterial ultrasonography and the risk of coronary event were performed using risk factor-adjusted Cox proportional hazards models. The incremental value of each marker over conventional risk factors was tested by calculating the likelihood ratio statistic between nested models, each with the Framingham risk or SCORE risk and with or without the marker studied. Data were analyzed using the STATA 9.0 statistical software (STATA Corp, Texas).</p>
</sec>
</sec>
<sec id="section8-0003319711414865">
<title>Results</title>
<p>Details with regard to the composition of the cohort are shown in <xref ref-type="fig" rid="fig1-0003319711414865">Figure 1</xref>
. Description of the characteristics of the 2561 participants, including the prevalence of major cardiovascular risk factors, is given in <xref ref-type="table" rid="table1-0003319711414865">Table 1</xref>
. The sample studied had the usual characteristics of patients consulting at a prevention center for the management of risk factors: more than three quarters of the patients were dyslipidemic, and practically half were hypertensive.</p>
<fig id="fig1-0003319711414865" position="float">
<label>Figure 1.</label>
<caption>
<p>Study population. CVD, indicates cardiovascular disease; ET, exercise testing.</p>
</caption>
<graphic xlink:href="10.1177_0003319711414865-fig1.tif"/>
</fig>
<table-wrap id="table1-0003319711414865" position="float">
<label>Table 1.</label>
<caption>
<p>Basic Characteristic of the Sample<sup><xref ref-type="table-fn" rid="table-fn1-0003319711414865">a</xref></sup></p>
</caption>
<graphic alternate-form-of="table1-0003319711414865" xlink:href="10.1177_0003319711414865-table1.tif"/>
<table>
<thead>
<tr>
<th>n = 2561</th>
<th>
</th>
<th>Range</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age (years)</td>
<td>51.6 ± 10.5</td>
<td>18-80</td>
</tr>
<tr>
<td>Women—n (%)</td>
<td>978 (38.2)</td>
<td>
</td>
</tr>
<tr>
<td>Educational level—n (%)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Primary school</td>
<td>801 (31.3)</td>
<td>
</td>
</tr>
<tr>
<td> Secondary education</td>
<td>816 (31.9)</td>
<td>
</td>
</tr>
<tr>
<td> Higher education</td>
<td>944 (36.6)</td>
<td>
</td>
</tr>
<tr>
<td>Hypertension—n (%)</td>
<td>1235 (48.2)</td>
<td>
</td>
</tr>
<tr>
<td>Low-density lipoprotein (LDL) ≥ 160 mg/dL or treatment—n (%)</td>
<td>1805 (70.5)</td>
<td>
</td>
</tr>
<tr>
<td>Triglycerides ≥ 1.5 mg/dL or treatment—n (%)</td>
<td>1477 (57.7)</td>
<td>
</td>
</tr>
<tr>
<td>Current smoking—n (%)</td>
<td>613 (23.9)</td>
<td>
</td>
</tr>
<tr>
<td>Diabetes—n (%)</td>
<td>175 (6.8)</td>
<td>
</td>
</tr>
<tr>
<td>Overweight—n (%)</td>
<td>1411 (55.1)</td>
<td>
</td>
</tr>
<tr>
<td>Obesity—n (%)</td>
<td>406 (15.9)</td>
<td>
</td>
</tr>
<tr>
<td>Waist ≥ 102 cm (men); ≥?88 (women)—n (%)</td>
<td>612 (23.9)</td>
<td>
</td>
</tr>
<tr>
<td>Metabolic syndrome—n (%)</td>
<td>473 (18.5)</td>
<td>
</td>
</tr>
<tr>
<td>Alcohol &gt; 40 g/d—n (%)</td>
<td>380 (14.9)</td>
<td>
</td>
</tr>
<tr>
<td>High physical activity—n (%)</td>
<td>485 (18.9)</td>
<td>
</td>
</tr>
<tr>
<td>Familial history—n (%)</td>
<td>271 (10.6)</td>
<td>
</td>
</tr>
<tr>
<td>At least 2 major risk factors—n (%)</td>
<td>1724 (67.4)</td>
<td>
</td>
</tr>
<tr>
<td>Lipid lowering drug at inclusion—n (%)</td>
<td>675 (26.4)</td>
<td>
</td>
</tr>
<tr>
<td> Statin</td>
<td>476 (18.6)</td>
<td>
</td>
</tr>
<tr>
<td> Fibrate</td>
<td>188 (7.3)</td>
<td>
</td>
</tr>
<tr>
<td> Cholestyramine</td>
<td>30 (1.2)</td>
<td>
</td>
</tr>
<tr>
<td> Omega 3</td>
<td>20 (0.8)</td>
<td>
</td>
</tr>
<tr>
<td>Lipid-lowering drug at follow-up—n (%)</td>
<td>761 (29.7)</td>
<td>
</td>
</tr>
<tr>
<td>BP-lowering drug at inclusion—n (%)</td>
<td>461 (18.0)</td>
<td>
</td>
</tr>
<tr>
<td>10-Year risk (Framingham; mean ± SD<bold>)</bold>
</td>
<td>10.8 ± 7.8</td>
<td>
</td>
</tr>
<tr>
<td>10-Year risk (SCORE; mean ± SD<bold>)</bold>
</td>
<td>2.0 ± 2.9</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0003319711414865">
<p>
<sup>a</sup> For risk factor definition, see the Methods section.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>
<xref ref-type="table" rid="table2-0003319711414865">Table 2</xref>
presents the results obtained from the Doppler ultrasonography taken at inclusion. Almost a quarter of the population had femoral or carotid plaque. In all, 4 out of 10 had anomalies such as plaque or stenosis. Approximately 63% presented abnormalities upon exploration according to the criteria defined above. No aneurysm of the abdominal aorta (defined by a diameter of the abdominal aorta &gt;3 cm) was detected. Half the sample was at moderate or high risk according to the Framingham risk score or SCORE models and 10% of the population was at high cardiovascular risk corresponding, for Framingham, to a risk at 10 years higher than 20%, and for SCORE, to a risk at 10 years of 5%.</p>
<table-wrap id="table2-0003319711414865" position="float">
<label>Table 2.</label>
<caption>
<p>Results of Carotid and Femoral Ultrasonography</p>
</caption>
<graphic alternate-form-of="table2-0003319711414865" xlink:href="10.1177_0003319711414865-table2.tif"/>
<table>
<thead>
<tr>
<th>n = 2561</th>
<th>n (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Carotid stenosis &gt;50%</td>
<td>87 (3.4)</td>
</tr>
<tr>
<td>Carotid plaque</td>
<td>591 (23.1)</td>
</tr>
<tr>
<td>Femoral plaque</td>
<td>655 (25.6)</td>
</tr>
<tr>
<td>Intima–media thickness (IMT), mm</td>
<td>0.63 ± 0.14</td>
</tr>
<tr>
<td>No abnormality at US<sup>
<xref ref-type="table-fn" rid="table-fn2-0003319711414865">
a
</xref>
</sup>
</td>
<td>946 (37.3)</td>
</tr>
<tr>
<td>1 abnormality at US</td>
<td>1095 (43.1)</td>
</tr>
<tr>
<td>2 abnormalities at US</td>
<td>441 (17.4)</td>
</tr>
<tr>
<td>3 or 4 abnormalities at US</td>
<td>57 (2.2)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0003319711414865">
<p>
<sup>a</sup> Number of abnormalities: IMT &gt;0.63, carotid or femoral plaque, carotid stenosis.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>During a mean follow-up of 6 years, 94 coronary events were noted including 8 sudden deaths or coronary deaths, 24 cases of nonfatal myocardial infarction, 15 acute coronary syndrome, and 47 cases of stable angina. This corresponded to a rate of coronary events cumulated over the entire follow-up of 13%. In addition, 36 deaths from noncoronary causes were recorded as well as 12 cases of stroke and 70 revascularization procedures (not included in the event studied).</p>
<p>The relative risks of coronary event according to convention risk factors and the results of arterial ultrasonography are presented in <xref ref-type="table" rid="table3-0003319711414865">Table 3</xref>
. Both for high IMT and for the presence of carotid and femoral plaque, the association with the prognosis persisted after adjustment for risk, whatever be the method of assessment (Framingham risk score or SCORE), after adjustment for treatment with statins, and after adjustment for the other Doppler ultrasonography abnormalities. Stenosis of the carotid artery did not seem to offer any information of prognostic value in this model (results not shown). <xref ref-type="fig" rid="fig2-0003319711414865">Figure 2</xref>
illustrates the differences in event-free survival as a function of the number of abnormalities observed at the carotid and femoral Doppler ultrasonography examination. The risk increased significantly with the number of abnormalities and from the very first.</p>
<table-wrap id="table3-0003319711414865" position="float">
<label>Table 3.</label>
<caption>
<p>Relative Risks of Coronary Events According to Conventional Risk Factors and the Results of Arterial US (Hazard Ratios and 95% CI)</p>
</caption>
<graphic alternate-form-of="table3-0003319711414865" xlink:href="10.1177_0003319711414865-table3.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Crude HR</th>
<th>Adjusted HR (1)</th>
<th>Adjusted HR (2)</th>
<th>Multivariate HR (3)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Carotid stenosis</td>
<td>1.58 (0.73-3.44)</td>
<td>1.62 (0.74-3.51)</td>
<td>1.57 (0.72-3.41)</td>
<td align="center">–</td>
</tr>
<tr>
<td>Carotid plaque</td>
<td>3.69 (2.46-5.54)<sup><xref ref-type="table-fn" rid="table-fn4-0003319711414865">a</xref></sup>
</td>
<td>2.81 (1.84-4.27)<sup><xref ref-type="table-fn" rid="table-fn4-0003319711414865">a</xref></sup>
</td>
<td>2.79 (1.83-4.25)<sup><xref ref-type="table-fn" rid="table-fn4-0003319711414865">a</xref></sup>
</td>
<td>2.17 [1.67-3.42]<sup><xref ref-type="table-fn" rid="table-fn4-0003319711414865">a</xref></sup>
</td>
</tr>
<tr>
<td>Femoral plaque</td>
<td>3.05 (2.03-4.59)<sup><xref ref-type="table-fn" rid="table-fn4-0003319711414865">a</xref></sup>
</td>
<td>2.33 (1.53-3.55)<sup><xref ref-type="table-fn" rid="table-fn4-0003319711414865">a</xref></sup>
</td>
<td>2.28 (1.50-3.47)<sup><xref ref-type="table-fn" rid="table-fn4-0003319711414865">a</xref></sup>
</td>
<td>1.64 [1.04-2.58]<sup>
<xref ref-type="table-fn" rid="table-fn5-0003319711414865">
b
</xref>
</sup>
</td>
</tr>
<tr>
<td>IMT &gt; 0.63</td>
<td>2.78 (1.67-4.61)<sup><xref ref-type="table-fn" rid="table-fn4-0003319711414865">a</xref></sup>
</td>
<td>2.20 (1.31-3.67)<sup><xref ref-type="table-fn" rid="table-fn6-0003319711414865">c</xref></sup>
</td>
<td>2.18 (1.30-3.64)<sup><xref ref-type="table-fn" rid="table-fn6-0003319711414865">c</xref></sup>
</td>
<td>1.73 [1.02-3.94]<xref ref-type="table-fn" rid="table-fn5-0003319711414865">b</xref></td>
</tr>
<tr>
<td>No. of abnormalities</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> 0 (ref)</td>
<td>1</td>
<td>1</td>
<td>1</td>
<td align="center">–</td>
</tr>
<tr>
<td> 1</td>
<td>2.73 (0.35-5.49)<sup>
<xref ref-type="table-fn" rid="table-fn6-0003319711414865">
c
</xref>
</sup>
</td>
<td>2.39 (1.18-4.84)<xref ref-type="table-fn" rid="table-fn6-0003319711414865">b</xref></td>
<td>2.35 (1.16-4.74)<xref ref-type="table-fn" rid="table-fn6-0003319711414865">b</xref></td>
<td align="center">–</td>
</tr>
<tr>
<td> 2</td>
<td>5.59 (2.72-11.49)<sup><xref ref-type="table-fn" rid="table-fn4-0003319711414865">a</xref></sup>
</td>
<td>4.25 (2.04-8.86)<sup><xref ref-type="table-fn" rid="table-fn4-0003319711414865">a</xref></sup>
</td>
<td>4.10 (1.96-8.54)<sup><xref ref-type="table-fn" rid="table-fn4-0003319711414865">a</xref></sup>
</td>
<td align="center">–</td>
</tr>
<tr>
<td> 3</td>
<td>23.14 (10.5-51.1)<sup><xref ref-type="table-fn" rid="table-fn4-0003319711414865">a</xref></sup>
</td>
<td>14.4 (6.30-33.1)<sup><xref ref-type="table-fn" rid="table-fn4-0003319711414865">a</xref></sup>
</td>
<td>14.83 (6.47-33.9)</td>
<td align="center">–</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0003319711414865">
<p>Abbreviations: 1, adjusted for Framingham pretest risk; 2, adjusted for Framingham pretest risk and statin treatment at follow-up; 3, adjusted for Framingham pretest risk and statin treatment at follow-up and for the other US abnormalities; CI, confidence interval.</p>
</fn>
<fn id="table-fn4-0003319711414865">
<p>Significance level: <sup>a</sup> <italic>P</italic> &lt; .001</p>
</fn>
<fn id="table-fn5-0003319711414865">
<p>
<sup>b</sup> 
<italic>P</italic> &lt; .05.</p>
</fn>
<fn id="table-fn6-0003319711414865">
<p>
<sup>c</sup> 
<italic>P</italic> &lt; .01.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig2-0003319711414865" position="float">
<label>Figure 2.</label>
<caption>
<p>Coronary event free survival according to the findings at arterial ultrasonography.</p>
<p>Number of participants at risk</p>
</caption>
<graphic xlink:href="10.1177_0003319711414865-fig2.tif"/>
</fig>
</sec>
<sec id="section9-0003319711414865">
<title>Discussion</title>
<p>With 40% of participants having plaque or stenosis, a moderately increased IMT or the presence of carotid or femoral artery plaque was related to prognosis, after adjustment for risk of the Framingham risk score and for treatment with statins. Our study also showed that the presence of at least 1 abnormality at Doppler ultrasonography significantly increased the risk of occurrence of major coronary events independently of traditional cardiovascular risk factors taken into account in the standard models for assessing absolute cardiovascular risk.</p>
<p>Given the characteristics of our population, the mean IMT figures measured in our cohort corresponded to figures obtained in the majority of studies,<sup>
<xref ref-type="bibr" rid="bibr4-0003319711414865">4</xref>,<xref ref-type="bibr" rid="bibr6-0003319711414865">6</xref>,<xref ref-type="bibr" rid="bibr16-0003319711414865">16</xref><xref ref-type="bibr" rid="bibr17-0003319711414865"/><xref ref-type="bibr" rid="bibr18-0003319711414865"/><xref ref-type="bibr" rid="bibr19-0003319711414865"/><xref ref-type="bibr" rid="bibr20-0003319711414865"/>–<xref ref-type="bibr" rid="bibr21-0003319711414865">21</xref>
</sup> including those carried out in the general population in the same geographic zone. We chose to calculate the risks with regard to coronary event for a figure of IMT higher than the mean figure measured in the sample. An IMT higher than 0.63 mm was associated with a doubled risk of occurrence of coronary event. Several studies<sup>
<xref ref-type="bibr" rid="bibr18-0003319711414865">18</xref>,<xref ref-type="bibr" rid="bibr22-0003319711414865">22</xref><xref ref-type="bibr" rid="bibr23-0003319711414865"/>–<xref ref-type="bibr" rid="bibr24-0003319711414865">24</xref>
</sup> have assessed the prognostic value of measurement of IMT using a threshold figure of 0.8 mm. Others used threshold figures of up to 1.2 mm thickness.<sup>
<xref ref-type="bibr" rid="bibr5-0003319711414865">5</xref>,<xref ref-type="bibr" rid="bibr25-0003319711414865">25</xref><xref ref-type="bibr" rid="bibr26-0003319711414865"/><xref ref-type="bibr" rid="bibr27-0003319711414865"/>–<xref ref-type="bibr" rid="bibr28-0003319711414865">28</xref>
</sup> In the present study, we showed that even for small increases in IMT, there is a significant relation between the IMT and the occurrence of coronary events, including after taking into account treatment with statins, which are known to likely reduce the IMT.</p>
<p>The prevalence of plaque in carotid and femoral arteries in our cohort was respectively 23% and 25%, which corresponds to the prevalence observed in most of the studies carried out in asymptomatic patients.<sup>
<xref ref-type="bibr" rid="bibr7-0003319711414865">7</xref>,<xref ref-type="bibr" rid="bibr8-0003319711414865">8</xref>,<xref ref-type="bibr" rid="bibr29-0003319711414865">29</xref><xref ref-type="bibr" rid="bibr30-0003319711414865"/>–<xref ref-type="bibr" rid="bibr31-0003319711414865">31</xref>
</sup> The presence of plaque in femoral arteries was strongly correlated with the occurrence of coronary event. We also found a significant connection between the presence of plaque in carotid arteries and the occurrence of coronary event, in accordance with the data in the literature.<sup>
<xref ref-type="bibr" rid="bibr6-0003319711414865">6</xref>,<xref ref-type="bibr" rid="bibr7-0003319711414865">7</xref>,<xref ref-type="bibr" rid="bibr32-0003319711414865">32</xref>
</sup> However, it should be specified that our study did not look at the relation between the occurrence of coronary event and morphological nature of the plaque. For an equal level of risk, a patient with plaque in the femoral artery had 3 times greater risk of occurrence of a major cardiovascular event than a patient with none. Another strength of this study is that we showed that each location seemed to provide independent information since the relation to risk remained statistically very significant after adjustment on another location. We were also able to show that the presence of at least 1 Doppler ultrasonography abnormality significantly increased the risk of occurrence of coronary events independently of traditional cardiovascular risk factors taken into account by the standard models for assessing absolute cardiovascular risk.</p>
<p>The presence of asymptomatic carotid stenosis higher than 50% was not significantly correlated with an increase in risk of coronary event. Numerous studies<sup>
<xref ref-type="bibr" rid="bibr33-0003319711414865">33</xref><xref ref-type="bibr" rid="bibr34-0003319711414865"/>–<xref ref-type="bibr" rid="bibr35-0003319711414865">35</xref>
</sup> have, however, shown a significant link between stenosis and cardiovascular morbidity and mortality. A lack of power due to the low prevalence of stenoses may in part explain this result. In our cohort, the prevalence of stenoses above 50% was only 3%. The prevalence<sup>
<xref ref-type="bibr" rid="bibr36-0003319711414865">36</xref>,<xref ref-type="bibr" rid="bibr37-0003319711414865">37</xref>
</sup> of carotid stenoses in a population with high cardiovascular risk, in addition to high blood pressure, is usually 5% to 10%. Our study seemed therefore to underestimate the prevalence of carotid stenosis. Before the age of 50, the frequency<sup>
<xref ref-type="bibr" rid="bibr38-0003319711414865">38</xref>
</sup> of stenosis is lower than 1%, which might explain in part the low prevalence in our sample. It should be pointed out that stroke was not included in the cardiovascular events studied in this analysis, contrary to the majority of the studies mentioned.</p>
<p>Our study also had a number of limitations. One of the principal concerns was the generalization of the results since our sample was not strictly population-based. The patients had been sent by their doctor or had come of their own accord, which can be responsible for a healthy screening effect. In addition, it might be seen that our sample presents a pretest risk level higher than that in the general population. In fact, only the prevalence of hypertension and hypercholesterolemia were higher than that observed in the general population in the same region,<sup>
<xref ref-type="bibr" rid="bibr39-0003319711414865">39</xref>
</sup> and this patient profile at intermediate risk corresponds to persons examined in daily practice for cardiovascular risk assessment. Only 10% of the patients were considered to be at high risk prior to the test. In addition, the incidence of major coronary events was comparable to that observed in the general population in the same country.<sup>
<xref ref-type="bibr" rid="bibr39-0003319711414865">39</xref>
</sup>
</p>
<p>Simply taking into account traditional risk factors can underestimate the overall cardiovascular risk in asymptomatic patients where the true cardiovascular risk is intermediate or high. Performing a Doppler ultrasonography could therefore enable identification of these asymptomatic patients at high cardiovascular risk in populations wrongly considered as a low risk by algorithms and who might then require intensive treatment. This type of examination might also be useful to help increase the motivation and observance of treatment in patients undergoing primary prevention, as was demonstrated with regard to exercise testing.<sup>
<xref ref-type="bibr" rid="bibr40-0003319711414865">40</xref>
</sup>
</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors thank the EVADEC-VASC research assistant team: Delphine Baudoin, Bex Camille, Béatrice Montalegre, and Monique Paillol.</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="fn1-0003319711414865">
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0003319711414865">
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The EVADEC survey was supported by a grant from Bristol-Myers-Squibb France. The funding source has had no role in the design and conduct of the study, collection, management, analysisand interpretation of the data.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0003319711414865">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Odell</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Kannel</surname>
<given-names>WB</given-names>
</name>
</person-group>. <article-title>An updated coronary risk profile. A statement for health professionals</article-title>. <source>Circulation</source>. <year>1991</year>;<volume>83</volume>(<issue>1</issue>):<fpage>356</fpage>–<lpage>362</lpage>.</citation>
</ref>
<ref id="bibr2-0003319711414865">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conroy</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Pyorala</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>AP</given-names>
</name>
<etal/>
</person-group>. <article-title>Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project</article-title>. <source>Eur Heart J</source>. <year>2003</year>;<volume>24</volume>(<issue>11</issue>):<fpage>987</fpage>–<lpage>1003</lpage>.</citation>
</ref>
<ref id="bibr3-0003319711414865">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pearson</surname>
<given-names>TA</given-names>
</name>
</person-group>. <article-title>New tools for coronary risk assessment: what are their advantages and limitations?</article-title> <source>Circulation</source>. <year>2002</year>;<volume>105</volume>(<issue>7</issue>):<fpage>886</fpage>–<lpage>892</lpage>.</citation>
</ref>
<ref id="bibr4-0003319711414865">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrieres</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Elias</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ruidavets</surname>
<given-names>JB</given-names>
</name>
<etal/>
</person-group>. <article-title>Carotid intima-media thickness and coronary heart disease risk factors in a low-risk population</article-title>. <source>J Hypertens</source>. <year>1999</year>;<volume>17</volume>(<issue>6</issue>):<fpage>743</fpage>–<lpage>748</lpage>.</citation>
</ref>
<ref id="bibr5-0003319711414865">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambless</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Heiss</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Folsom</surname>
<given-names>AR</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993</article-title>. <source>Am J Epidemiol</source>. <year>1997</year>;<volume>146</volume>(<issue>6</issue>):<fpage>483</fpage>–<lpage>494</lpage>.</citation>
</ref>
<ref id="bibr6-0003319711414865">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salonen</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Salonen</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Ultrasonographically assessed carotid morphology and the risk of coronary heart disease</article-title>. <source>Arterioscler Thromb</source>. <year>1991</year>;<volume>11</volume>(<issue>5</issue>):<fpage>1245</fpage>–<lpage>1249</lpage>.</citation>
</ref>
<ref id="bibr7-0003319711414865">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Honda</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kugiyama</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Echolucent carotid plaques predict future coronary events in patients with coronary artery disease</article-title>. <source>J Am Coll Cardiol</source>. <year>2004</year>;<volume>43</volume>(<issue>7</issue>):<fpage>1177</fpage>–<lpage>1184</lpage>.</citation>
</ref>
<ref id="bibr8-0003319711414865">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belcaro</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nicolaides</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Ramaswami</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1))</article-title>. <source>Atherosclerosis</source>. <year>2001</year>;<volume>156</volume>(<issue>2</issue>):<fpage>379</fpage>–<lpage>387</lpage>.</citation>
</ref>
<ref id="bibr9-0003319711414865">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cournot</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Boccalon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cambou</surname>
<given-names>JP</given-names>
</name>
<etal/>
</person-group>. <article-title>Accuracy of the screening physical examination to identify subclinical atherosclerosis and peripheral arterial disease in asymptomatic subjects</article-title>. <source>J Vasc Surg</source>. <year>2007</year>;<volume>46</volume>(<issue>6</issue>):<fpage>1215</fpage>–<lpage>1221</lpage>.</citation>
</ref>
<ref id="bibr10-0003319711414865">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cournot</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Taraszkiewicz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cambou</surname>
<given-names>JP</given-names>
</name>
<etal/>
</person-group>. <article-title>Additional prognostic value of physical examination, exercise testing, and arterial ultrasonography for coronary risk assessment in primary prevention</article-title>. <source>Am Heart J</source>. <year>2009</year>;<volume>158</volume>(<issue>5</issue>):<fpage>845</fpage>–<lpage>851</lpage>.</citation>
</ref>
<ref id="bibr11-0003319711414865">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marques-Vidal</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ruidavets</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Amouyel</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Change in cardiovascular risk factors in France, 1985-1997</article-title>. <source>Eur J Epidemiol</source>. <year>2004</year>;<volume>19</volume>(<issue>1</issue>):<fpage>25</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr12-0003319711414865">
<label>12</label>
<citation citation-type="journal">
<article-title>Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report</article-title>. <source>Circulation</source>. <year>2002</year>;<volume>106</volume>(<issue>25</issue>):<fpage>3143</fpage>–<lpage>3421</lpage>.</citation>
</ref>
<ref id="bibr13-0003319711414865">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Odell</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Kannel</surname>
<given-names>WB</given-names>
</name>
</person-group>. <article-title>An updated coronary risk profile. A statement for health professionals</article-title>. <source>Circulation</source>. <year>1991</year>;<volume>83</volume>(<issue>1</issue>):<fpage>356</fpage>–<lpage>362</lpage>.</citation>
</ref>
<ref id="bibr14-0003319711414865">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicolaides</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shifrin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bradbury</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Angiographic and duplex grading of internal carotid stenosis: can we overcome the confusion?</article-title> <source>J Endovasc Surg</source>. <year>1996</year>;<volume>3</volume>(<issue>2</issue>):<fpage>158</fpage>–<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr15-0003319711414865">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ducimetiere</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ruidavets</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Montaye</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yarnell</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study</article-title>. <source>Int J Epidemiol</source>. <year>2001</year>;<volume>30</volume>(<issue>5</issue>):<fpage>1057</fpage>–<lpage>1062</lpage>.</citation>
</ref>
<ref id="bibr16-0003319711414865">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gariepy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Salomon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Denarie</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Sex and topographic differences in associations between large-artery wall thickness and coronary risk profile in a French working cohort: the AXA Study</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>1998</year>;<volume>18</volume>(<issue>4</issue>):<fpage>584</fpage>–<lpage>590</lpage>.</citation>
</ref>
<ref id="bibr17-0003319711414865">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denarie</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gariepy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chironi</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Distribution of ultrasonographically-assessed dimensions of common carotid arteries in healthy adults of both sexes</article-title>. <source>Atherosclerosis</source>. <year>2000</year>;<volume>148</volume>(<issue>2</issue>):<fpage>297</fpage>–<lpage>302</lpage>.</citation>
</ref>
<ref id="bibr18-0003319711414865">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Depairon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tutta</surname>
<given-names>P</given-names>
</name>
<name>
<surname>van Melle</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hayoz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kappenberger</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Darioli</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>[Reference values of intima-medial thickness of carotid and femoral arteries in subjects aged 20 to 60 years and without cardiovascular risk factors]</article-title>. <source>Arch Mal Coeur Vaiss</source>. <year>2000</year>;<volume>93</volume>(<issue>6</issue>):<fpage>721</fpage>–<lpage>726</lpage>.</citation>
</ref>
<ref id="bibr19-0003319711414865">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Edelstein</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wollman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bond</surname>
<given-names>MG</given-names>
</name>
</person-group>. <article-title>Ultrasonic-pathological comparison of the human arterial wall. Verification of intima-media thickness</article-title>. <source>Arterioscler Thromb</source>. <year>1993</year>;<volume>13</volume>(<issue>4</issue>):<fpage>482</fpage>–<lpage>486</lpage>.</citation>
</ref>
<ref id="bibr20-0003319711414865">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Leary</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Polak</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Kronmal</surname>
<given-names>RA</given-names>
</name>
<etal/>
</person-group>. <article-title>Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group</article-title>. <source>Stroke</source>. <year>1992</year>;<volume>23</volume>(<issue>12</issue>):<fpage>1752</fpage>–<lpage>1760</lpage>.</citation>
</ref>
<ref id="bibr21-0003319711414865">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bots</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Hoes</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Koudstaal</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Hofman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grobbee</surname>
<given-names>DE</given-names>
</name>
</person-group>. <article-title>Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study</article-title>. <source>Circulation</source>. <year>1997</year>;<volume>96</volume>(<issue>5</issue>):<fpage>1432</fpage>–<lpage>1437</lpage>.</citation>
</ref>
<ref id="bibr22-0003319711414865">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penckofer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Filliung</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Labropoulos</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Non-invasive cardiovascular risk assessment in women with type 2 diabetes</article-title>. <source>J Vasc Nurs</source>. <year>2005</year>;<volume>23</volume>(<issue>1</issue>):<fpage>2</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr23-0003319711414865">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wofford</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Kahl</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>McKinney</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Toole</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Crouse</surname>
<given-names>JR</given-names>
<suffix>3rd</suffix>
</name>
</person-group>. <article-title>Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis</article-title>. <source>Arterioscler Thromb</source>. <year>1991</year>;<volume>11</volume>(<issue>6</issue>):<fpage>1786</fpage>–<lpage>1794</lpage>.</citation>
</ref>
<ref id="bibr24-0003319711414865">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Touboul</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Labreuche</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vicaut</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Amarenco</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk</article-title>. <source>Stroke</source>. <year>2005</year>;<volume>36</volume>(<issue>8</issue>):<fpage>1741</fpage>–<lpage>1745</lpage>.</citation>
</ref>
<ref id="bibr25-0003319711414865">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aboyans</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lacroix</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Postil</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting</article-title>. <source>J Am Coll Cardiol</source>. <year>2005</year>;<volume>46</volume>(<issue>5</issue>):<fpage>815</fpage>–<lpage>820</lpage>.</citation>
</ref>
<ref id="bibr26-0003319711414865">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aminbakhsh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mancini</surname>
<given-names>GB</given-names>
</name>
</person-group>. <article-title>Carotid intima-media thickness measurements: what defines an abnormality? A systematic review</article-title>. <source>Clin Invest Med</source>. <year>1999</year>;<volume>22</volume>(<issue>4</issue>):<fpage>149</fpage>–<lpage>157</lpage>.</citation>
</ref>
<ref id="bibr27-0003319711414865">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kablak-Ziembicka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tracz</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Przewlocki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pieniazek</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sokolowski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Konieczynska</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Association of increased carotid intima-media thickness with the extent of coronary artery disease</article-title>. <source>Heart</source>. <year>2004</year>;<volume>90</volume>(<issue>11</issue>):<fpage>1286</fpage>–<lpage>1290</lpage>.</citation>
</ref>
<ref id="bibr28-0003319711414865">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollander</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hak</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Koudstaal</surname>
<given-names>PJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study</article-title>. <source>Stroke</source>. <year>2003</year>;<volume>34</volume>(<issue>10</issue>):<fpage>2367</fpage>–<lpage>2372</lpage>.</citation>
</ref>
<ref id="bibr29-0003319711414865">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kitamura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yamagishi</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Ankle-arm blood pressure index as a correlate of preclinical carotid atherosclerosis in elderly Japanese men</article-title>. <source>Atherosclerosis</source>. <year>2006</year>;<volume>184</volume>(<issue>2</issue>):<fpage>420</fpage>–<lpage>424</lpage>.</citation>
</ref>
<ref id="bibr30-0003319711414865">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathiesen</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Bonaa</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Joakimsen</surname>
<given-names>O</given-names>
</name>
</person-group>. <article-title>Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the Tromso study</article-title>. <source>Circulation</source>. <year>2001</year>;<volume>103</volume>(<issue>17</issue>):<fpage>2171</fpage>–<lpage>2175</lpage>.</citation>
</ref>
<ref id="bibr31-0003319711414865">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jingzi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Umahara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takasaki</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Prognosis of the elderly with asymptomatic atherosclerotic plaques of the carotid arteries</article-title>. <source>Intern Med</source>. <year>2002</year>;<volume>41</volume>(<issue>7</issue>):<fpage>526</fpage>–<lpage>531</lpage>.</citation>
</ref>
<ref id="bibr32-0003319711414865">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nossen</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Vierzigmann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>[Calcified plaques of extracranial carotid arteries and left ventricular geometry as predictors of coronary artery disease]</article-title>. <source>Med Klin (Munich)</source>. <year>2003</year>;<volume>98</volume>(<issue>2</issue>):<fpage>72</fpage>–<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr33-0003319711414865">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joakimsen</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Bonaa</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Mathiesen</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Stensland-Bugge</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Arnesen</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Prediction of mortality by ultrasound screening of a general population for carotid stenosis: the Tromso Study</article-title>. <source>Stroke</source>. <year>2000</year>;<volume>31</volume>(<issue>8</issue>):<fpage>1871</fpage>–<lpage>1876</lpage>.</citation>
</ref>
<ref id="bibr34-0003319711414865">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogren</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hedblad</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Isacsson</surname>
<given-names>SO</given-names>
</name>
<name>
<surname>Janzon</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jungquist</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lindell</surname>
<given-names>SE</given-names>
</name>
</person-group>. <article-title>Ten year cerebrovascular morbidity and mortality in 68 year old men with asymptomatic carotid stenosis</article-title>. <source>BMJ</source>. <year>1995</year>;<volume>310</volume>(<issue>6990</issue>):<fpage>1294</fpage>–<lpage>1298</lpage>.</citation>
</ref>
<ref id="bibr35-0003319711414865">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nadareishvili</surname>
<given-names>ZG</given-names>
</name>
<name>
<surname>Rothwell</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Beletsky</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pagniello</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Norris</surname>
<given-names>JW</given-names>
</name>
</person-group>. <article-title>Long-term risk of stroke and other vascular events in patients with asymptomatic carotid artery stenosis</article-title>. <source>Arch Neurol</source>. <year>2002</year>;<volume>59</volume>(<issue>7</issue>):<fpage>1162</fpage>–<lpage>1166</lpage>.</citation>
</ref>
<ref id="bibr36-0003319711414865">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pujia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rubba</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>MP</given-names>
</name>
</person-group>. <article-title>Prevalence of extracranial carotid artery disease detectable by echo-Doppler in an elderly population</article-title>. <source>Stroke</source>. <year>1992</year>;<volume>23</volume>(<issue>6</issue>):<fpage>818</fpage>–<lpage>822</lpage>.</citation>
</ref>
<ref id="bibr37-0003319711414865">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Hoeg</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>D’Agostino</surname>
<given-names>RB</given-names>
</name>
<etal/>
</person-group>. <article-title>Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis</article-title>. <source>N Engl J Med</source>. <year>1997</year>;<volume>337</volume>(<issue>8</issue>):<fpage>516</fpage>–<lpage>522</lpage>.</citation>
</ref>
<ref id="bibr38-0003319711414865">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Riordain</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>O’Donnell</surname>
<given-names>JA</given-names>
</name>
</person-group>. <article-title>Realistic expectations for the patient with intermittent claudication</article-title>. <source>Br J Surg</source>. <year>1991</year>;<volume>78</volume>(<issue>7</issue>):<fpage>861</fpage>–<lpage>863</lpage>.</citation>
</ref>
<ref id="bibr39-0003319711414865">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuulasmaa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tunstall-Pedoe</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dobson</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations</article-title>. <source>Lancet</source>. <year>2000</year>;<volume>355</volume>(<issue>9205</issue>):<fpage>675</fpage>–<lpage>687</lpage>.</citation>
</ref>
<ref id="bibr40-0003319711414865">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruce</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>DeRouen</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Hossack</surname>
<given-names>KF</given-names>
</name>
</person-group>. <article-title>Pilot study examining the motivational effects of maximal exercise testing to modify risk factors and health habits</article-title>. <source>Cardiology</source>. <year>1980</year>;<volume>66</volume>(<issue>2</issue>):<fpage>111</fpage>–<lpage>119</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>